We are proud to announce that Nanoligent has won the Santander X Award 2025 in the category of Best University Start-up from UAB, at the awards ceremony held on June 19th at the Universitat Autònoma de Barcelona (UAB).
This award, promoted by Banco Santander and Emprèn UAB, recognizes entrepreneurial projects with high social and economic impact. Out of 26 projects submitted — including 9 start-ups — Nanoligent was selected as the winner by a jury of experts from the investment, biotech, and innovation sectors.
At Nanoligent, a UAB spin-off, we develop highly specific cancer treatments based on nanotechnology. Our approach aims to revolutionize cancer therapy by delivering more effective treatments with fewer side effects.
The award includes a €4,000 prize and a nomination to compete in the Santander X Spain Award | University 2025.
We are honored to receive this recognition and grateful to the UAB and Santander for supporting innovation and entrepreneurship.
